Retinal Diseases And Treatments
101 researchers across 10 institutions
Research in retinal diseases and treatments investigates the causes, progression, and potential interventions for conditions affecting the eye's retina. This work encompasses understanding the cellular and molecular mechanisms underlying inherited and acquired retinal disorders, such as age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. Investigations employ advanced imaging techniques, genetic analysis, and preclinical models to identify therapeutic targets and evaluate novel treatment strategies, including gene therapy, pharmacologic agents, and regenerative medicine approaches.
This research holds significant relevance for Arkansas by addressing health challenges prevalent in the state. Diabetic retinopathy, a leading cause of blindness, disproportionately affects populations with higher rates of diabetes, a concern in Arkansas. Advancements in understanding and treating retinal diseases contribute to improving visual health outcomes for Arkansans, potentially reducing healthcare burdens and enhancing quality of life. Furthermore, this area supports the growth of the biotechnology and healthcare sectors within the state.
This field draws upon expertise from ophthalmology, medical imaging, disease mechanisms, and health sciences. The research involves a broad spectrum of engagement, with active investigations occurring across multiple institutions within Arkansas, fostering collaboration and diverse perspectives on complex retinal conditions.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Nancy J. Rusch | UAMS | 42 | 4,961 | High Impact | |
| Paul H. Phillips | UAMS | 42 | 7,330 | High Impact | |
| Nalini S. Bora | UAMS | 33 | 3,432 | High Impact | |
| Xiaotong Han | UAMS | 29 | 3,452 | High Impact | |
| Abdelrahman Y. Fouda | UAMS | 28 | 2,020 | Grant PI High Impact | |
| Carol Morris | UAMS | 25 | 1,990 | High Impact | |
| Ranu Jung | University of Arkansas | 23 | 2,161 | High Impact Grants | |
| Valeriy V. Lyzogubov | UAMS | 22 | 1,848 | High Impact | |
| F. Matonti | UA Monticello | 21 | 1,611 | High Impact | |
| Alexander Chen | University of Central Arkansas | 19 | 1,420 | ||
| Sayena Jabbehdari | UAMS | 18 | 797 | ||
| Mohammed F. Faramawi | UAMS | 18 | 1,087 | ||
| Zhengyang Liu | UAMS | 17 | 813 | ||
| Sami H. Uwaydat | UAMS | 15 | 1,042 | ||
| Esraa Shosha | UAMS | 14 | 648 | ||
| Aytan Musayeva | UAMS | 14 | 689 | ||
| Ahmed F. Shakarchi | UAMS | 14 | 714 | ||
| Muhammad Z. Chauhan | UAMS | 14 | 685 | ||
| William Henry | UAMS | 14 | 983 | ||
| A. J. Cunningham | UAMS | 14 | 1,501 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Retinal Diseases And Treatments in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Johns Hopkins University 3,064
- 2 Harvard University 3,047
- 3 Massachusetts Eye and Ear Infirmary 2,219
- 4 Doheny Eye Institute 1,975
- 5 Johns Hopkins Medicine 1,838
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Retinal Diseases And Treatments.